Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
AMRI (NASDAQ: AMRI) today announced that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y. site to other sites within AMRI and will cease operations in Syracuse by the end of June 2014. The actions ...
read more
Thursday, November 13, 2014
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQB: AVXL), announced today that it has received regulatory approval from the Ethics Committee in Australia to initiate a Phase 2a clinical trial of its proprietary compound, ANAVEX 2-73, as ...
read more
Monday, February 09, 2015
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX: AVXL) today announced that Christopher U. Missling, PhD, President and Chief Executive Officer, will present at the 17th Annual BIO CEO & Investor Conference on Tuesday, February 10, 2015...
read more
Thursday, December 18, 2014
Anavex Life Sciences Corp. (“Anavex” or the “Company”) (OTCQX: AVXL), a clinical-stage biopharmaceutical company developing novel drug candidates to treat Alzheimer’s disease, other diseases of the central nervous system (CNS) and various types of ...
read more
Greenwich, CT, March 15, 2012 - Timothy C. Tyson, Aptuit Chairman, announced that effective immediately, Stuart E. Needleman has been named President and Chief Operating Officer of Aptuit LLC. Following the recent sale of the company’s Clinical ...
read more
Thursday, October 19, 2023
Aragen, a leading provider of contract research, development, and manufacturing services for the pharmaceutical, biotechnology, agrochemicals, and animal health sectors, has inaugurated its advanced formulations manufacturing facility in Hyderabad, ...
read more
Thursday, October 31, 2013
Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, today announces a three-year extension of its integrated contract drug discovery agreement with Genentech, a member of ...
read more
Wednesday, April 11, 2012
Esther Sadler-Williams, Senior Director Strategic Alliance Development, Clinical Supply Services at Catalent Pharma Solutions will lead two discussions, “Around the World in 80 Ways: How to Ensure a Lean and Efficient Clinical Distribution Supply ...
read more
Tuesday, October 29, 2019
Artelo Biosciences has selected Aptus Clinical as its CRO for the Company’s Phase 1b/2a randomized, placebo-controlled trial of ART27.13.
read more
Monday, December 06, 2021
ASLAN Pharmaceuticals announced the appointment of IQVIA Biotech, a provider of analytics, technology solutions, and clinical research services to the life sciences industry, as its preferred clinical research organization for logistics related to ...
read more
Tuesday, November 24, 2020
CCT Research announced its partnership with AstraZeneca to advance COVID-19 research. Together with local healthcare providers, CCT will facilitate clinical trials for the AZD1222 COVID-19 VACCINE, an investigational vaccine for the prevention of ...
read more
Tuesday, October 01, 2019
N-SIDE announced AstraZeneca has signed an agreement to implement the N-SIDE Suite for Clinical Trials.
read more
AUM Biosciences, a global clinical-stage biotech company, focused on discovering and developing novel targeted oncology therapies, has entered into a clinical trial collaboration and supply agreement with MSD, a tradename of Merck & Co., Inc., Rahway...
read more
Wednesday, November 19, 2014
Auxiliis, a full-service contract research organisation (CRO) dedicated exclusively to paediatric clinical trials, has raised EUR 1.3 million from Alliance Jura Hongrie, a Budapest-based venture capital fund.
read more
Tuesday, January 17, 2023
Avacta Group, a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics announces that AVA6000 continues to show a very favourable safety profile in the fourth dose cohort of the ALS-6000-101 dose escalation ...
read more